Biopharma Automation Market Outlook (2026–2030): Long-Term Industry Insights
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Automation In Biopharma Industry Market Expected To Scale Between 2026 And 2030?
The market for automation in the biopharma industry has experienced substantial growth in recent years. It is forecast to increase from $2.19 billion in 2025 to $2.35 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.1%. The expansion observed during the historic period can be ascribed to several factors, including the increasing complexity of biologic drug production, a rising demand for scalable biopharma manufacturing solutions, the early adoption of laboratory automation, the broader reach of contract manufacturing services, and continuous advancements in process control technologies.
The automation in biopharma industry market is predicted to experience significant expansion in the coming years. Its valuation is expected to reach $3.16 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.7%. This projected increase is fueled by factors such as greater investments in intelligent biomanufacturing facilities, the rising adoption of continuous manufacturing, the widening scope of personalized biologics production, a growing demand for automation that adheres to regulations, and an intensified focus on optimizing manufacturing efficiency. Significant developments expected during this forecast period involve the increased deployment of robotic manufacturing platforms, the rising integration of digital twin technologies, a broader application of automated quality control systems, the expansion of comprehensive end-to-end bioprocess automation, and an enhanced emphasis on data-driven manufacturing processes.
Access Your Free Sample Report For In-Depth Market Analysis:
What Factors Are Contributing To The Growth Of The Automation In Biopharma Industry Market?
The expanding integration of robots into pharmaceutical production is anticipated to fuel the expansion of the automation in biopharma industry market. These robots are sophisticated automated systems and machinery designed to execute diverse operations in the creation and packaging of pharmaceutical goods. Their common applications within pharmaceutical manufacturing encompass areas like secondary packaging, intralogistics, laboratory automation, pick and place, streamlining pharmacy processes, and personalized medicine, which leads to benefits such as increased productivity, improved accuracy, lower contamination risks, and enhanced safety for workers. As an example, the International Federation of Robotics, a professional non-profit organization based in Germany, reported that by September 2024, industrial robot installations within Europe’s manufacturing sector had climbed by 9%, setting a new record of 92,393 units. Of this total, the European Union accounted for 80% of installations, amounting to 73,534 units, which represented a 2% increase compared to the prior year. Consequently, the rising deployment of robots in pharmaceutical manufacturing is poised to accelerate the expansion of the automation in biopharma industry market.
What Are The Key Segment Divisions In The Automation In Biopharma Industry Market Segment Structure?
The automation in biopharma industry market covered in this report is segmented –
1) By Technology: Automation Technology, Digitization Technology
2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase
3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase
Subsegments:
1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)
2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology
What Trends Are Shaping The Future Of The Automation In Biopharma Industry Market?
Major companies are implementing automation within the biopharma industry market, with a focus on developing technological innovations such as robotic cell-therapy manufacturing platforms designed for the scalable, efficient, and error-reduced production of advanced therapies. A robotic cell-therapy manufacturing platform combines mobile robotics, aseptic fluid-handling systems, automated tube welding, and digital process control within a fully closed and modular framework, replacing traditional manual bioprocessing that is highly labor-intensive and uses open systems. For instance, in May 2023, Cellular Origins, a UK-based life sciences automation company, launched Constellation, a configurable robotic platform intended for advanced therapy manufacture. This platform integrates autonomous mobile robots, sterile fluid-transfer technology, and modular processing consoles, allowing for seamless incorporation into existing bioprocessing workflows. It boosts space efficiency by 30 times, decreases labor requirements by 16-fold, and cuts production costs by 51%, while also offering full digital interconnection for quality control and remote monitoring.
Which Organizations Are Engaged In The Automation In Biopharma Industry Market?
Major companies operating in the automation in biopharma industry market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.
Get The Full Automation In Biopharma Industry Market Report:
Which Region Is The Largest In The Automation In Biopharma Industry Market?
North America was the largest region in the automation in biopharma industry market in 2025. The regions covered in the automation in biopharma industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Automation In Biopharma Industry Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Automation In Biopharma Industry Market 2026, By The Business Research Company
Pharmacy Automation Systems Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmacy-automation-systems-global-market-report
Bioprocess Automation Market Report 2026
https://www.thebusinessresearchcompany.com/report/bioprocess-automation-global-market-report
Pharmacy Automation Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmacy-automation-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
